Cargando…

Comprehensive functional evaluation of variants of fibroblast growth factor receptor genes in cancer

Various genetic alterations of the fibroblast growth factor receptor (FGFR) family have been detected across a wide range of cancers. However, inhibition of FGFR signaling by kinase inhibitors demonstrated limited clinical effectiveness. Herein, we evaluated the transforming activity and sensitivity...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakamura, Ikuko Takeda, Kohsaka, Shinji, Ikegami, Masachika, Ikeuchi, Hiroshi, Ueno, Toshihide, Li, Kunhua, Beyett, Tyler S., Koyama, Takafumi, Shimizu, Toshio, Yamamoto, Noboru, Takahashi, Fumiyuki, Takahashi, Kazuhisa, Eck, Michael J., Mano, Hiroyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285406/ https://www.ncbi.nlm.nih.gov/pubmed/34272467 http://dx.doi.org/10.1038/s41698-021-00204-0

Ejemplares similares

Development of an optimal protocol for molecular profiling of tumor cells in pleural effusions at single‐cell level
por: Nakamura, Ikuko Takeda, et al.
Publicado: (2021)

High-Throughput Functional Evaluation of MAP2K1 Variants in Cancer
por: Mizuno, Sho, et al.
Publicado: (2023)

Preclinical assessment of combination therapy of EGFR tyrosine kinase inhibitors in a highly heterogeneous tumor model
por: Ikeuchi, Hiroshi, et al.
Publicado: (2022)

Highly sensitive fusion detection using plasma cell‐free RNA in non‐small‐cell lung cancers
por: Hasegawa, Nobuhiko, et al.
Publicado: (2021)

Activation of insulin‐like growth factor‐1 receptor confers acquired resistance to osimertinib in non‐small cell lung cancer with EGFR T790M mutation
por: Hayakawa, Daisuke, et al.
Publicado: (2019)

High-throughput functional evaluation of BRCA2 variants of unknown significance
por: Ikegami, Masachika, et al.
Publicado: (2020)

MicroSEC filters sequence errors for formalin-fixed and paraffin-embedded samples
por: Ikegami, Masachika, et al.
Publicado: (2021)

Structure and RAF family kinase isoform selectivity of type II RAF inhibitors tovorafenib and naporafenib
por: Tkacik, Emre, et al.
Publicado: (2023)

Detection of circulating sarcoma tumor cells using a microfluidic chip-type cell sorter
por: Hasegawa, Nobuhiko, et al.
Publicado: (2019)

Emerging PD-1/PD-L1 targeting immunotherapy in non-small cell lung cancer: Current status and future perspective in Japan, US, EU, and China
por: Mizuno, Takaaki, et al.
Publicado: (2022)

Comprehensive assay for the molecular profiling of cancer by target enrichment from formalin‐fixed paraffin‐embedded specimens
por: Kohsaka, Shinji, et al.
Publicado: (2019)

First‐in‐human phase I study of E7090, a novel selective fibroblast growth factor receptor inhibitor, in patients with advanced solid tumors
por: Koyama, Takafumi, et al.
Publicado: (2020)

Gefitinib in the treatment of nonsmall cell lung cancer with activating epidermal growth factor receptor mutation
por: Nurwidya, Fariz, et al.
Publicado: (2016)

Scapular Angiomatoid Fibrous Histiocytoma with EWSR1-CREB1 Fusion in an Adult Patient
por: Kobayashi, Hiroshi, et al.
Publicado: (2021)

Safety and pharmacokinetics of milademetan, a MDM2 inhibitor, in Japanese patients with solid tumors: A phase I study
por: Takahashi, Shunji, et al.
Publicado: (2021)

PEDT-12 NATIONWIDE LANDSCAPE OF GENOMIC ANALYSIS OF PEDIATRIC CENTRAL NERVOUS SYSTEM TUMORS
por: Watanabe, Yuko, et al.
Publicado: (2022)

Extensive analysis of 59 sarcoma‐related fusion genes identified pazopanib as a potential inhibitor to COL1A1‐PDGFB fusion gene
por: Hirose, Takeshi, et al.
Publicado: (2023)

Epithelial Mesenchymal Transition in Drug Resistance and Metastasis of Lung Cancer
por: Nurwidya, Fariz, et al.
Publicado: (2012)

Molecular Mechanisms Contributing to Resistance to Tyrosine Kinase-Targeted Therapy for Non-Small Cell Lung Cancer
por: Nurwidya, Fariz, et al.
Publicado: (2012)

Impact of Hepatitis Virus on the Feasibility and Efficacy of Anticancer Agents in Patients With Hepatocellular Carcinoma in Phase I Clinical Trials
por: Koyama, Takafumi, et al.
Publicado: (2019)

Infection risk with PI3K-AKT-mTOR pathway inhibitors and immune checkpoint inhibitors in patients with advanced solid tumours in phase I clinical trials
por: Fujiwara, Yutaka, et al.
Publicado: (2020)

Prevalence of psychological distress, quality of life, and satisfaction among patients and family members following comprehensive genomic profiling testing: Protocol of the Quality of life for Cancer genomics and Advanced Therapeutics (Q-CAT) study
por: Nishino, Makoto, et al.
Publicado: (2023)

From tumor hypoxia to cancer progression: the implications of hypoxia-inducible factor-1 expression in cancers
por: Nurwidya, Fariz, et al.
Publicado: (2012)

Genetic Testing Distinguishes Multiple Chondroid Chordomas with Neuraxial Bone Metastases from Multicentric Tumors
por: Kobayashi, Hiroshi, et al.
Publicado: (2020)

A first-in-human, phase 1 study of the NEDD8 activating enzyme E1 inhibitor TAS4464 in patients with advanced solid tumors
por: Yamamoto, Noboru, et al.
Publicado: (2021)

Oral formulation of bendamustine hydrochloride for patients with advanced solid tumors; a phase 1 study
por: Shimizu, Toshio, et al.
Publicado: (2022)

Strategies for an effective tobacco harm reduction policy in Indonesia
por: Nurwidya, Fariz, et al.
Publicado: (2014)

Haploinsufficiency of the folliculin gene leads to impaired functions of lung fibroblasts in patients with Birt–Hogg–Dubé syndrome
por: Hoshika, Yoshito, et al.
Publicado: (2016)

Cerebral infarction in advanced non-small cell lung cancer: a case control study
por: Kato, Motoyasu, et al.
Publicado: (2016)

First‐in‐human study of the cancer peptide vaccine TAS0313 in patients with advanced solid tumors
por: Kondo, Shunsuke, et al.
Publicado: (2021)

LSD1/KDM1 isoform LSD1+8a contributes to neural differentiation in small cell lung cancer
por: Jotatsu, Takanobu, et al.
Publicado: (2016)

Hemophagocytic syndrome after living donor liver transplantation: a case report with a review of the literature
por: Iseda, Norifumi, et al.
Publicado: (2018)

Prognostic benefit of comprehensive genomic profiling in clinical practice remains uncertain
por: Ikegami, Masachika
Publicado: (2023)

Practical consideration for successful sequential tumor biopsies in first-in-human trials
por: Koyama, Takafumi, et al.
Publicado: (2022)

Solitary splenic metastasis of pulmonary carcinoid: A rare case report and literature review
por: Nishikawa, Toshio, et al.
Publicado: (2017)

A novel S269C mutation in fibroblast growth factor receptor 3 in a Japanese child with hypochondroplasia
por: Takahashi, Ikuko, et al.
Publicado: (2018)

Novel Calcium-Binding Ablating Mutations Induce Constitutive RET Activity and Drive Tumorigenesis
por: Tabata, Junya, et al.
Publicado: (2022)

Nanostring-based screening for tyrosine kinase fusions in inflammatory myofibroblastic tumors
por: Kurihara, Taisei, et al.
Publicado: (2020)

Experience with Support at Workplaces for People with Young Onset Dementia: A Qualitative Evaluation of Being Open about Dementia
por: Omote, Shizuko, et al.
Publicado: (2023)

Pemetrexed for advanced non-small cell lung cancer patients with interstitial lung disease
por: Kato, Motoyasu, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3cnj6ba1qmgodflkbf4vojq315